ArticleCancer biology & therapy2019

Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.